Madrigal pharmaceuticals, inc. (MDGL)
Balance Sheet / Quarterly
Mar'20Dec'19Sep'19Jun'19Mar'19Dec'18Sep'18Jun'18Mar'18Dec'17Sep'17Jun'17Mar'17Dec'16Sep'16Jun'16Mar'16Dec'15Sep'15Jun'15Mar'15Dec'14Sep'14Jun'14Mar'14Dec'13Sep'13Jun'13Mar'13Dec'12Sep'12Jun'12Mar'12Dec'11Sep'11Jun'11Dec'10
Assets
Current assets:
Cash and cash equivalents

66,651

46,697

89,486

72,508

47,493

57,379

38,046

264,861

38,125

148,627

12,960

34,797

8,215

19,145

8,393

10,756

42,815

306

45,537

32,003

33,255

46,024

68,478

96,811

52,034

48,490

25,477

33,783

34,962

81,512

29,442

25,593

34,550

30,075

20,643

25,891

31,310

Marketable securities

341,859

392,348

364,124

393,888

430,332

426,339

450,492

225,444

144,700

42,900

49,177

32,369

31,912

21,355

31,164

32,259

9,227

-

42,715

66,331

43,351

51,666

50,802

15,249

26,753

42,986

27,907

36,420

55,432

19,087

25,697

19,063

22,840

9,650

30,017

36,998

19,663

Other receivable - related party

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

7

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Collaboration receivable

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

116

Prepaid expenses and other current assets

976

1,152

1,712

2,389

565

1,483

767

968

374

485

583

781

225

707

1,632

1,820

554

50

1,975

2,213

1,367

1,656

2,911

2,264

1,605

765

1,358

1,637

1,475

786

803

839

608

561

1,362

832

431

Total current assets

409,486

440,197

455,322

468,785

478,390

485,201

489,305

491,273

183,199

192,012

62,720

67,947

40,352

41,207

41,190

44,835

52,596

363

90,227

100,547

77,973

99,346

122,191

114,324

80,392

92,241

54,742

71,840

91,869

101,385

55,942

45,495

57,998

40,286

52,022

63,721

51,520

Property and equipment, net

1,373

1,184

181

211

240

227

244

255

279

301

111

120

5

3

1

103

374

-

561

714

855

1,024

1,134

1,264

1,408

1,553

1,488

1,620

1,350

1,174

1,205

1,166

1,324

1,407

1,316

1,403

2,181

Right-of-use asset

598

675

751

826

930

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Goodwill and other intangibles assets

-

-

-

-

-

-

-

-

-

-

-

-

-

-

315

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Other assets

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

226

278

564

305

331

358

384

1,409

433

464

481

458

466

503

519

631

530

497

366

Total assets

411,457

442,056

456,254

469,822

479,560

485,428

489,549

491,528

183,478

192,313

62,831

68,067

40,357

41,210

41,507

44,938

52,970

363

91,014

101,539

79,392

100,675

123,656

115,946

82,184

95,203

56,663

73,924

93,700

103,017

57,613

47,164

59,841

42,324

53,868

65,621

54,067

Liabilities and Stockholders' Equity
Current liabilities:
Accounts payable

1,115

1,178

773

446

4,376

2,487

1,031

588

1,420

1,929

1,400

1,285

2,780

762

1,159

680

744

102

1,424

3,018

3,738

3,139

4,442

5,226

5,810

6,589

5,693

5,222

5,719

5,661

3,690

3,468

3,040

3,467

2,921

1,999

1,925

Accrued expenses

24,269

23,637

14,381

11,564

5,778

5,957

5,611

4,848

4,874

8,125

7,123

5,151

3,126

4,038

2,755

-

-

70

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Lease liability

319

315

310

306

302

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Convertible promissory notes payable - related parties

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

48,595

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Advances payable - related party

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

500

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Accrued interest on advances - related party

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

9

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Accrued contract research costs

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

1,202

2,737

-

17,206

14,728

12,511

12,317

14,276

12,987

12,488

10,407

8,352

5,911

4,901

4,761

3,719

3,776

4,007

2,841

3,010

2,871

2,511

Other accrued liabilities

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

1,450

2,826

-

5,047

5,529

5,408

6,177

4,994

5,212

4,765

5,718

4,497

3,624

2,839

5,127

3,643

3,119

2,530

4,594

3,249

2,909

4,194

Current portion of capital lease obligations

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

22

33

-

43

43

42

42

42

41

41

42

4

8

11

13

13

13

12

12

20

31

201

Deferred collaboration revenue

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

3,303

4,446

4,572

Current portion of term loans

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

10

2,299

-

6,913

9,207

9,221

9,214

9,207

9,200

9,261

9,451

7,385

5,306

3,081

7,924

7,900

7,878

6,055

4,234

4,613

3,093

3,333

Total current liabilities

25,703

25,130

15,464

12,316

10,456

8,444

6,642

5,436

6,294

10,054

8,523

6,436

5,906

4,800

3,915

3,364

8,639

49,276

30,633

32,525

30,920

30,889

32,961

32,666

32,365

32,207

25,931

20,071

16,551

23,486

18,965

18,254

15,644

15,148

17,116

15,349

16,736

Long-term liabilities:
Lease liability

279

361

441

520

598

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Capital lease obligations, net of current portion

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

11

22

33

43

54

65

75

85

-

-

-

1

4

8

11

14

17

20

26

Deferred collaboration revenue, net of current portion

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

2,159

Term loans, net of current portion

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

10

2,299

4,607

6,913

9,217

11,520

13,820

16,120

18,417

20,545

4,464

6,454

8,438

10,416

12,388

12,154

13,815

11,667

Total long term liabilities

279

361

441

520

598

-

-

-

-

-

-

-

-

-

-

-

-

-

11

32

2,332

4,650

6,967

9,282

11,595

13,905

16,120

18,417

20,545

4,465

6,458

8,446

10,427

12,402

12,171

13,835

13,852

Total liabilities

25,982

25,491

15,905

12,836

11,054

8,444

6,642

5,436

6,294

10,054

8,523

6,436

5,906

4,800

3,915

3,364

8,639

49,276

30,644

32,557

33,252

35,539

39,928

41,948

43,960

46,112

42,051

38,488

37,096

27,951

25,423

26,700

26,071

27,550

29,287

29,184

30,588

Commitments and contingencies (Note 12)

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

-

-

-

0

-

-

-

0

-

-

-

0

-

-

0

Stockholders' equity:
Preferred stock, par value $0.0001 per share authorized: 5,000,000 shares at March 31, 2020 and December 31, 2019; 1,969,797 shares issued and outstanding at March 31, 2020 and December 31, 2019

-

-

-

-

-

-

0

0

0

-

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

Common stock, par value $0.0001 per share authorized: 200,000,000 at March 31, 2020 and December 31, 2019; 15,429,154 shares issued and outstanding at March 31, 2020 and December 31, 2019

2

2

2

2

2

2

2

2

1

1

1

1

1

1

1

14

14

0

14

13

11

11

11

10

9

9

7

7

7

7

6

6

6

5

5

5

4

Additional paid-in-capital

644,413

639,567

635,535

630,550

622,678

616,573

610,845

605,418

290,182

288,750

152,276

151,247

115,692

111,691

105,161

757,626

757,081

6

756,053

747,055

704,403

702,694

700,927

671,240

613,180

600,477

541,849

540,155

538,538

536,277

475,273

448,555

447,226

413,196

412,262

411,375

374,528

Accumulated other comprehensive gain (loss)

415

216

292

485

178

-319

-143

-43

-174

-31

47

36

64

25

-12

81

4

-

11

-6

6

4

11

3

4

17

6

9

7

2

8

4

19

3

1

10

-3

Accumulated deficit

-259,400

-223,220

-195,480

-174,051

-154,352

-139,300

-127,797

-119,285

-112,825

-106,461

-98,016

-89,653

-81,306

-75,307

-67,558

-716,147

-712,768

-48,919

-695,708

-678,080

-658,280

-637,573

-617,221

-597,255

-574,969

-551,412

-527,250

-504,735

-481,948

-461,220

-443,097

-428,101

-413,481

-398,430

-387,687

-374,953

-351,050

Total stockholders' equity

385,475

416,565

440,349

456,986

468,506

476,984

482,907

486,092

177,184

182,259

54,308

61,631

34,451

36,410

37,591

41,574

44,331

-48,913

60,370

68,982

46,140

65,136

83,728

73,998

38,224

49,091

14,612

35,436

56,604

75,066

32,190

20,464

33,770

14,774

24,581

36,437

23,479

Total liabilities and stockholders' equity

411,457

442,056

456,254

469,822

479,560

485,428

489,549

491,528

183,478

192,313

62,831

68,067

40,357

41,210

41,507

44,938

52,970

363

91,014

101,539

79,392

100,675

123,656

115,946

82,184

95,203

56,663

73,924

93,700

103,017

57,613

47,164

59,841

42,324

53,868

65,621

54,067